BioIVT_4C_Logo w Tagline-01-1



Emerging Technologies in Diagnostics Symposium

OCTOBER 29, 2020
10 AM - 1 PM EST

Event Overview

BioIVT, a leading provider of biological specimens and specialty research services, supports your efforts in the development of new diagnostic assays. From companion diagnostic to point of care device testing, BioIVT has the access to the donor cohorts and biological specimens your assays and tests demand.

Join us (virtually) for a look into technologies that are changing the diagnostic assay landscape. Register now to attend our virtual symposium on Emerging Technologies in Diagnostics and listen to your colleagues from the diagnostic and discovery world discuss how their work is accelerating in vitro and companion diagnostic development.

Can We Buy You Lunch?

Since our event has transitioned to a virtual event, we would like to offer any registrants a $20, €20, UberEats voucher.  When you fill out the registration form below select  whether you'd like to receive our lunch voucher. The voucher will be sent 24 hours before the start of the event. 



RIslam_Circle HS
Rafiq Islam
Regional Vice President, Pharmaceutical Development Services, Smithers

Rafiq Islam is the Regional Vice President for the Pharmaceutical Development Services division responsible for scientific and operational leadership
of bioanalytical operations in Gaithersburg, MD
and Ewing, NJ. Prior to joining Smithers, he was
the Executive Director of small and large molecule bioanalytical services at Celerion Inc. He also serves
as the chairman of the scientific advisory board for Somru Bioscience Inc. With over 20 years of biotechnology and CRO industry experience,
Mr. Rafiq has authored and contributed to more
than 50 articles, industry whitepapers, and
numerous posters on the topic of regulated bioanalysis, biomarker, immunogenicity and biosimilars.


HTomlinson_Circle HS
Heather Tomlinson
Director of Clinical Diagnostics, Promega Corporation

Heather Baird Tomlinson is the Director for the
Global Clinical Diagnostics Strategic Business Unit at Promega Corporation bringing with her over a
decade of experience in the clinical diagnostics
market. Heather is responsible for the clinical
market segment at Promega, effectively leading
the team that drives the commercial strategy. Heather’s recent work focuses on microsatellite instability testing as a diagnostic test for predicting patient outcome to immune-oncology drugs. Heather has presented scientific evidence of the importance of MSI testing internationally, including in the United States, Europe, Asia, and Africa. Heather received her PhD in Pharmacology from Case Western University, and
her BS in Biochemistry from Ohio University.

KKohlmeier_Circle HS
Kevin Kohlmeier
Director of Marketing, InDevR, Inc

Kevin Kohlmeier, Bachelor’s Degree
in Biochemistry from the University of
Washington. Kevin started his career on the lab
bench working on crystallization of
recombinant bacterial proteins. Since that time
he has worked with several products in the
vaccine space, starting with InDevR in 2010. He
has worked as Product Manager for the
VaxArray Product line since 2017.


Opening Remarks, Biospecimens for Emerging Technologies in Diagnostics
Speaker: Cathie G. Miller, PhD, Director of Product Marketing, Personalized Medicine, BioIVT
Bioanalytical Method Validation – From Biomarkers to Companion Diagnostics
Speaker: Rafiq Islam, Regional Vice President, Smithers
Rapid Analytics for Vaccines Using InDevR's VaxArray Platform
Speaker: Kevin Kohlmeier, Director of Marketing, InDevR, Inc
Development of OncoMate™ MSI as a Companion Diagnostic for Immune Checkpoint Inhibitors
Speaker: Heather Tomlinson, Director of Clinical Diagnostics, Promega
Closing Remarks

Save Your Seat